Experienced in Acute Erythroid Leukemia (AEL)

Dr. Elliot M. Stieglitz

Hematology | Oncology
505 Parnassus Ave, M649 Box 0106, 
San Francisco, CA 
Experienced in Acute Erythroid Leukemia (AEL)
505 Parnassus Ave, M649 Box 0106, 
San Francisco, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elliot Stieglitz is a Hematologist and an Oncologist in San Francisco, California. Dr. Stieglitz is rated as an Experienced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), RASopathies, Acute Myeloid Leukemia (AML), and Splenectomy.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acute Erythroid Leukemia (AEL).

Specialties
Hematology
Oncology
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

505 Parnassus Ave, M649 Box 0106, San Francisco, CA 94143

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML.
Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML.
Enrollment Status: Active_not_recruiting
Publish Date: July 29, 2025
Intervention Type: Drug
Study Drug: Selinexor
Study Phase: Phase 1
A Phase 2 Study of the MEK Inhibitor Trametinib (NSC# 763093) in Children With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
A Phase 2 Study of the MEK Inhibitor Trametinib (NSC# 763093) in Children With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Enrollment Status: Active_not_recruiting
Publish Date: July 16, 2025
Intervention Type: Procedure, Drug
Study Drug: Trametinib
Study Phase: Phase 2
View 1 Less Clinical Trial

71 Total Publications

Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Similar Doctors
Experienced in Acute Erythroid Leukemia (AEL)
Dr. Dita A. Gratzinger
Hematology
Experienced in Acute Erythroid Leukemia (AEL)
Dr. Dita A. Gratzinger
Hematology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (27.5 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances

Dita Gratzinger is a Hematologist in Stanford, California. Dr. Gratzinger is rated as a Distinguished provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). Her top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, T-Cell Lymphoma, and Tissue Biopsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stieglitz's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile